Rax (mouse protein) and PACT (human ortholog) are the only known activators of PKR (double-stranded RNA dependent kinase).
| Inventor | Institute |
|---|---|
| Richard Bennett | University of Florida Research Foundation |
| Cat. #: | 158410 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell signaling and signal transduction |
| Application: | ELISA ; WB ; IHC |
| Target: | Phosphorylated interferon-inducible double strane RNA-dependent protein kinease/Protein activator of the interferon-induced protein kinase (RAX/PACT) |
| Reactivity: | Human ; Rat ; Mouse |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | RAX/PACT; PRKRA |
|---|---|
| Product description: | Rax (mouse protein) and PACT (human ortholog) are the only known activators of PKR (double-stranded RNA dependent kinase). Rax and PACT share 98% amino acid sequence homology and contain three conserved dsRNA binding motifs. Phosphorylation of Serine 18 of RAX is required for PKR activation, which is known to be involved in the host anti-viral response, and can act as a signaling mediator by cytokines, growth factors and even tumor supressors. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | Synthetic peptide corresponding to amino acids 13-25, including phosphorylated Serine 18, of mouse PACT protein |
| Target background: | Rax (mouse protein) and PACT (human ortholog) are the only known activators of PKR (double-stranded RNA dependent kinase). Rax and PACT share 98% amino acid sequence homology and contain three conserved dsRNA binding motifs. Phosphorylation of Serine 18 of RAX is required for PKR activation, which is known to be involved in the host anti-viral response, and can act as a signaling mediator by cytokines, growth factors and even tumor supressors. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Bennett et al. 2004. J Biol Chem. 279(41):42687-93. PMID: 15299031. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.